EyePoint Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 8.33 M | $66.52 M | 0.00% | 15.29% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 5.18 M | $41.35 M | 0.00% | 9.51% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.16 M | $33.20 M | 100.00% | 7.63% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 4.01 M | $40.80 M | 9.93% | 7.37% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 3.79 M | $30.29 M | 5.57% | 6.96% |
| VANGUARD GROUP INC | 11/13/2024 | 3.05 M | $24.35 M | 9.87% | 5.60% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 2.49 M | $19.91 M | -0.41% | 4.58% |
| MORGAN STANLEY | 11/14/2024 | 1.82 M | $14.51 M | -19.38% | 3.34% |
| ESSEX WOODLANDS MANAGEMENT, INC. | 11/14/2024 | 1.55 M | $12.40 M | 0.00% | 2.85% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.41 M | $11.24 M | 3.90% | 2.58% |
| PATIENT SQUARE CAPITAL LP | 11/14/2024 | 1.36 M | $10.88 M | 100.00% | 2.50% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 1.27 M | $10.14 M | -38.75% | 2.33% |
| STATE STREET CORP | 11/14/2024 | 1.22 M | $9.71 M | -0.32% | 2.23% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.22 M | $9.71 M | 53.55% | 2.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.20 M | $9.58 M | 16.15% | 2.20% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 1.09 M | $8.74 M | 0.00% | 2.01% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 1.05 M | $8.39 M | 2,000.00% | 1.93% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 1.04 M | $8.29 M | 62.00% | 1.91% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 922,335 | $7.37 M | 0.00% | 1.69% |
| FINEPOINT CAPITAL LP | 11/13/2024 | 707,404 | $5.65 M | 0.00% | 1.30% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 502,965 | $4.02 M | 74.62% | 0.92% |
| LAURION CAPITAL MANAGEMENT LP | 11/14/2024 | 460,006 | $3.68 M | -57.11% | 0.84% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 458,411 | $3.66 M | 127.69% | 0.84% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 457,052 | $3.65 M | -23.88% | 0.84% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 451,318 | $3.61 M | -28.45% | 0.83% |
| UBS GROUP AG | 11/14/2024 | 401,159 | $3.21 M | 111.24% | 0.74% |
| WOODLINE PARTNERS LP | 11/14/2024 | 400,000 | $3.20 M | 100.00% | 0.73% |
| JPMORGAN CHASE & CO | 12/26/2024 | 371,758 | $2.97 M | 1,171.32% | 0.68% |
| AXA S.A. | 11/14/2024 | 263,558 | $2.11 M | 0.03% | 0.48% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 251,348 | $2.01 M | 0.00% | 0.46% |
| BARCLAYS PLC | 11/19/2024 | 245,045 | $1.96 M | 410.38% | 0.45% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 187,437 | $1.50 M | 22.67% | 0.34% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 171,764 | $1.37 M | 59.40% | 0.32% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 170,901 | $1.37 M | 2.22% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 167,206 | $1.34 M | -18.39% | 0.31% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 166,500 | $1.33 M | -5.56% | 0.31% |
| ARTIA GLOBAL PARTNERS LP | 11/14/2024 | 156,300 | $1.25 M | 53.99% | 0.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 149,300 | $1.19 M | -49.71% | 0.27% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 142,763 | $1.14 M | 5.91% | 0.26% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 10/10/2024 | 142,144 | $1.14 M | 234.16% | 0.26% |
| CI PRIVATE WEALTH, LLC | 11/12/2024 | 130,662 | $1.04 M | 2.42% | 0.24% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 125,890 | $1.01 M | 100.00% | 0.23% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2024 | 123,933 | $988,985 | -0.95% | 0.23% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 119,025 | $951,010 | -1.40% | 0.22% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 104,946 | $837,469 | -17.81% | 0.19% |
| MYDA ADVISORS LLC | 11/13/2024 | 100,000 | $799,000 | 0.00% | 0.18% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 100,000 | $799,000 | 0.00% | 0.18% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 96,796 | $773,400 | 97.71% | 0.18% |
| SWISS NATIONAL BANK | 11/07/2024 | 96,600 | $771,834 | 3.76% | 0.18% |
| STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2024 | 96,007 | $767,096 | -31.19% | 0.18% |
EyePoint Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 172 institutional investors and hedge funds held shares of EyePoint Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Cormorant Asset Management, LP: 8.33 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 5.18 M
BlackRock Funding, Inc. /DE: 4.16 M
FRANKLIN RESOURCES INC: 4.01 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 3.79 M
VANGUARD GROUP INC: 3.05 M
107.44% of EyePoint Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 58.92 M shares in the last 24 months. This purchase volume represents approximately $424.85 M in transactions.